3h
Korea University Researchers Develop Ultrasensitive Method to Detect Low-Frequency Cancer Mutations
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero ...
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a ...
20d
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.
Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback